Market research
600479.SHG ZhuZhou QianJin Pharmaceutical Co.,Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 5B
- P/E ratio
- 14.14
- Analyst target
- 15.22
- Dividend yield
- 3.8%
- Beta
- 0.21
Community
Investor discussion
1 comment
Sign in to join the 600479.SHG discussion.
5 years, 5 months ago
ZhuZhou QianJin Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 2.6% below its 200 day moving average.
From a valuation standpoint, the stock is 89.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.0.
ZhuZhou QianJin Pharmaceutical Co.,Ltd's total revenue rose by 6.5% to $974M since the same quarter in the previous year.
Its net income has dropped by 37.8% to $83M since the same quarter in the previous year.
Finally, its free cash flow grew by 123.5% to $54M since the same quarter in the previous year.
Based on the above factors, ZhuZhou QianJin Pharmaceutical Co.,Ltd gets an overall score of 3/5.